% | $
Quotes you view appear here for quick access.

Geron Corporation Message Board

  • mruyog mruyog Mar 22, 2013 10:00 AM Flag

    Who From Management Must Be Fired?

    Stifel Nicolaus analyst Dr. Klein's criticism of Geron management's flawed plans may be reflective of the rift that may have developed between the company management and Stifel since the BioTime deal was accepted and company management's priority for oncology programs selected. Dr. Klein certainly has a serious point and that is reflected in the consistent share-price slide almost to its historic low and large volume selloffs soon after his comments were published. There is no doubt in my mind that the institutional investor community considered his comments to be very credidle and serious. In my view, the flaw was management's selection of not prioritizing short-telomere solid-tumor application before anything else, including the ET application. That would have avoided unnecessary costs of its trials for all breast and other solid-tumor cancers only to declare that the trials "failed" which was really not such a failure but surely was a catastrophe for the share price!! What a stupidity!!! If the teleomere-length study was first taken up and then the trials were specifically determined for short-telomeresolid-tumor applications, it would have been a glorious story for the share price.

    So, who was responsible for that nonsense? I suspect three of them: Kelsey, Scarlett and Behr. I am not sure Huh should be added or not. But, Vanguard, being the largest shareholder must be mad after Klein's comments and may be getting to the bottom of it! I will not be surprised if Vanguard and other major stakeholder(s) move to remove the real culprit(s) for the flawed plan. Note that Vanguard alone holds more shares than all insiders combined!! If so, Scaelett's and surely Behr's days are numbered!! Kelsey may be difficult to replace fast; but, he surely would have been down in the eyes of Vanguard and such other major stakeholders.

    I think the recent slide may be a blessing in disguise for us long holders and we willhave to see if that is what is cooking up now.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.20-0.02(-0.90%)Sep 23 4:00 PMEDT